Online citations, reference lists, and bibliographies.
← Back to Search

Targeting Of Drugs 4

G. Gregoriadis, B. McCormack, G. Poste
Published 1994 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1016/0167-4889(92)90230-9
Opsonophagocytosis of liposomes by peritoneal macrophages and bone marrow reticuloendothelial cells.
S. Moghimi (1992)
10.1084/JEM.166.4.1144
Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages
D. Richman (1987)
Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligo-nucleotides: an in vitro model for treatment, Proc.NatI.Acad.Sci.USA
P. Zamecnik (1992)
10.1073/PNAS.83.17.6603
Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall.
V. Smirnov (1986)
Synthesis of 14C labelled acrylic derivatives: diethyl [3_14C] methylidene malonate and isobutyl[3- 14C] cyanoacrylate, J.Label.Comp.Radiopharm
J. L. De Keyser (1989)
Polyalkylcyanoacrylates as colloidal drug carriers.
P. Couvreur (1988)
Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.
Q. V. van Hoesel (1984)
Comparative inhibition of ras p21 protein synthesis with phosphorus-modified antisense oligonucleotides.
E. H. Chang (1989)
10.1093/NAR/20.21.5691
Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity.
A. Thierry (1992)
10.1016/0014-4827(61)90092-1
A study of particulate intestinal absorption and hepatocellular uptake. Use of polystyrene latex particles.
E. Sanders (1961)
Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.
S. Huang (1992)
10.1016/0014-5793(85)80927-3
Tomato lectin resists digestion in the mammalian alimentary canal and binds to intestinal villi without deleterious effects
D. Kilpatrick (1985)
10.1042/BJ1290123
Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats.
G. Gregoriadis (1972)
intestine, Biol.of the Cell
P. Artursson (1984)
10.1210/MEND.6.6.1323055
Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line.
P. Murphy (1992)
10.1111/j.1749-6632.1989.tb24016.x
IL‐6 Is the Principal Factor Produced by Synovia of Patients with Rheumatoid Arthritis That Induces B‐Lymphocytes to Secrete Immunoglobulins
Y. Nawata (1989)
10.1201/9781315140575
CRC Handbook of solubility parameters and other cohesion parameters
A. M. Barton (1983)
1989a, Human red blood cells
M. Magnani (1989)
10.1016/0005-2736(91)90337-8
Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles.
J. Senior (1991)
Growth inhibition of human tumor cell lines by antisense oligonucleotides designed to inhibit p120 expression.
L. Perlaky (1993)
IL-6 is produced by osteoblasts and induces bone resorption.
Y. Ishimi (1990)
10.1016/0005-2736(91)90201-I
Pharmacokinetics of stealth versus conventional liposomes: effect of dose.
T. Allen (1991)
10.1126/SCIENCE.3293213
Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro.
M. Cooney (1988)
Specific targeting with polyethyleneglycol-modified liposomes
G. Storm (1993)
Ribozymes: Understanding and improving their activity and specificity, Intl.Conf.on
T. Cech (1993)
10.1016/0167-5699(90)90173-7
Biological and clinical aspects of interleukin 6.
T. Hirano (1990)
10.1126/SCIENCE.2470150
Stereochemistry of RNA cleavage by the Tetrahymena ribozyme and evidence that the chemical step is not rate-limiting.
J. Mcswiggen (1989)
Enhanced RNase H activity with methylphosphonodiester/phosphodiester chimeric antisense oligodeoxynucleotides.
R. V. Giles (1992)
10.1016/0014-5793(90)81016-H
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
A. Klibanov (1990)
10.1016/0168-3659(90)90133-E
Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches
J. Eldridge (1990)
Pharmacokinetics, tumor localization, and safety of DoxWM (liposomal doxorubicin) in AIDS patients with Kaposi's sarcoma, Proc.Am.Soc.Ciin.Oncol
D. W. Northfelt (1993)
10.1016/0024-3205(91)90480-Y
Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera.
S. Akhtar (1991)
10.1002/AR.1091550412
Light and electron microscopy of intestinal ferritin absorption. Observations in sensitized and nonsensitized hamsters (Mesocricetus auratus)
D. Bockman (1966)
10.1016/0169-409X(90)90020-S
Intestinal translocation of particulates — implications for drug and antigen delivery
D. O'hagan (1990)
Killing of intraphagocytic Staph.aureus
proteins (1978)
Substituted acrylates, US
I. S. Ponticello (1977)
10.1038/bjc.1991.169
Collagen production by macrophages in tumour encapsulation and dormancy.
J. Vaage (1991)
Inhibition of murine retrovirus-induced immunodeficiency disease by dideoxycytidine and dideoxycytidine 5'-triphosphate.
L. Rossi (1993)
10.1016/s0021-9258(18)60979-2
Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation.
J. M. Braughler (1987)
10.1016/0168-3659(91)90058-L
Polyalkylcyanoacrylate nanoparticles as drug carrier: present state and perspectives
P. Couvreur (1991)
Etude du mecanisme de degradation des nanoparticles de polycyanoacrylate d'alkyle
D. Leyh (1984)
The methodology used and tests to ensure the maintenance of lectin activity
Hussain (1994)
10.1016/0378-4274(85)90046-3
Toxicity determined in vitro by morphological alterations and neutral red absorption.
E. Borenfreund (1985)
10.1016/0006-2952(83)90289-7
Phospholipid composition of small unilamellar liposomes containing melphalan influences drug action in mice bearing PC6 tumours.
P. Large (1983)
Monoclonal antibody-directed targeting of fluorescent polystyrene microspheres to Peyer's patch M cells.
J. Pappo (1991)
Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.
L. Mayer (1989)
10.1016/0014-5793(94)00351-3
Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes
S. Moghimi (1994)
Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice.
A. Gabizon (1982)
10.1016/0168-3659(90)90013-J
Nanocapsules as carriers for oral peptide delivery
C. Damgé (1990)
HlV Inhibition by antisense oligodeoxynucleotides, Nucleosides Nucleotides
L. Blesert (1991)
10.1016/0378-5173(89)90223-8
Targeting of microspheres to sites of inflammation
L. Ilium (1989)
10.1016/0014-5793(71)80109-6
Enzyme entrapment in liposomes
G. Gregoriadis (1971)
Chromic chloride: a coupling reagent for passive hemagglutination reactions.
E. Gold (1967)
10.1016/0024-3205(90)90405-G
Effect of a new synthetic free radical scavenger, 2-octadecyl ascorbic acid, on the mortality in mouse endotoxemia.
A. Nonaka (1990)
Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy.
G. Los (1989)
Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer.
J. Robert (1985)
10.1096/fasebj.5.10.1712326
Targeted therapy of human immunodeficiency virus‐related disease
H. Mitsuya (1991)
10.1152/PHYSIOLOGYONLINE.1989.4.4.146
The Physiology of the Liposome
G. Gregoriadis (1989)
Inhibition of human
T. L. Gerrard (1988)
Interleukin-1 and interleukin-l antagonism
Dinarello (1991)
Another group to which conjugation of oligonucleotides has been shown to improve cellular uptake significantly is poly-lysine
unconjugated oligomer (1987)
Techniques to study the opsonic effect of serum
S. M. Moghimi (1993)
Fate of injected liposomes: Observations on entrapped solute
Publising Co (1988)
10.3181/00379727-159-40336
Accumulation of Latex in Peyer's Patches and Its Subsequent Appearance in Villi and Mesenteric Lymph Nodes 1 2
M. Lefevre (1978)
10.1016/0169-4758(92)90151-Q
Tumor necrosis factors: The molecules and their emerging role in medicine
A. Severn (1992)
Liposomes as drug carriers in cancer chemotherapy
H. Ellens (1982)
10.1001/ARCHINTE.1970.00310120093014
Physiology and physiopathology of the reticuloendothelial system.
T. Saba (1970)
10.1016/0005-2736(91)90246-5
Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo.
T. Allen (1991)
Structure and function of intestinal M cells.
J. Trier (1991)
10.1016/0167-4889(93)90137-E
Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum.
S. Moghimi (1993)
Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes.
S. S. Williams (1993)
10.2337/diab.37.2.246
New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier
C. Damgé (1988)
Oral uptake of Lectin-Conjugated microspheres through the murine intestine
N. Hussain (1994)
10.1016/0168-3659(94)90079-5
Microparticulate absorption from the rat intestine
P. G. Jenkins (1994)
10.1042/BST0170690
Effect of positive charge of liposomes on their clearance from the blood and its relation to vesicle lipid composition
Lloyd Tan (1989)
10.1016/0021-9797(91)90043-8
Protein—surface interactions in the presence of polyethylene oxide
S. Jeon (1991)
10.1159/000200402
Relationship between survival and binding of plant lectins during small intestinal passage and their effectiveness as growth factors.
A. Pusztai (1990)
10.1016/0014-5793(83)80160-4
Red blood cell targeting to collagen‐coated surfaces
G. Samokhin (1983)
10.1111/j.2042-7158.1989.tb06429.x
The transport of microspheres from the gastro‐intestinal tract to inflammatory air pouches in the rat
H. O. Alpar (1989)
10.3109/08982109209010212
Long-circulating liposomes: Development and perspectives
A. L. Kiibanov (1992)
Polysialic acids: potential in drug
G. Gregoriadis (1993)
10.1111/J.2042-7158.1982.TB04678.X
Use of a lipid emulsion as a novel carrier for corticosteroids
Y. Mizushima (1982)
10.1016/0076-6879(87)49062-9
Large-scale entrapment of drugs into resealed red blood cells using a continuous-flow dialysis system.
C. Ropars (1987)
Thus, as with many other biological processes, the mechanisms affecting particle uptake by macrophages are controlled by a balance of competing (opsonins and dysopsonins) factors and processes
Moghimi (1992)
10.1002/ART.1780310104
Dissection of the mechanisms of immune injury in rheumatoid arthritis, using total lymphoid irradiation.
J. H. Gaston (1988)
10.1002/PEN.760130602
Gel permeation chromatography: A guide to data interpretation
J. Evans (1973)
Human monocyte or recombinant interleukin 1's are specific for the secretion of a metalloproteinase from chondrocytes.
J. Schnyder (1987)
10.1002/JPS.2600820617
Chromatographic analysis and pharmacokinetics of liposome-encapsulated doxorubicin in non-small-cell lung cancer patients.
L. Embree (1993)
Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
A. Gabizon (1994)
10.1073/PNAS.88.24.11460
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
D. Papahadjopoulos (1991)
Macrophage activation by MDP bound to neoglycoproteins: metastasis eradication in mice.
A. C. Roche (1985)
10.1016/0024-3205(87)90120-2
Targeting of colloidal particles to the bone marrow.
L. Illum (1987)
Structural elements determining transport and exchange processes in the liver, in: "Microspheres and Drug Therapy, Pharmaceutical
E. Wisse (1984)
Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants.
R. Mandrell (1982)
10.1093/JNCI/82.21.1706
Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study.
J. Treat (1990)
An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells.
H. Yokozaki (1993)
10.1073/PNAS.86.6.2040
Encapsulation of doxorubicin in liver-targeted erythrocytes increases the therapeutic index of the drug in a murine metastatic model.
E. Zocchi (1989)
Antimalarial activities of oligodeoxynucleotide phosphorothioates in chloroquine-resistant Plasmodium fa1ciparium, Proc.NatI.Acad.Sci.USA
E. Rapoport (1992)
10.1080/00325481.1949.11693821
Treatment of rheumatoid arthritis.
W. P. Holbrook (1949)
Intestinal barrier to large particulate in mice, Proc.Soc.Exp.BioI.Med
M. E. LeFevre (1989)
10.1016/0005-2736(92)90194-Q
Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes.
M. Woodle (1992)
10.1016/0005-2736(86)90105-7
Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient.
L. Mayer (1986)
Pigment resembling atmospheric dust in Peyer's patches.
S. Urbanski (1989)
10.1126/SCIENCE.1857967
Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes.
W. Pieken (1991)
10.1097/00002371-199210000-00003
Antisense Inhibition of Gene Expression: A Tool for Studying the Role of NMYC in the Growth and Differentiation of Neuroectoderm-Derived Cells
L. Neckers (1992)
10.1073/PNAS.83.6.1911
Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
H. Mitsuya (1986)
Rapid nuclear accumulation of injected oligodeoxyribonucleotides.
D. Chin (1990)
10.1159/000163304
Particles and macrophages in murine Peyer's patches.
M. Lefevre (1985)
2.1.2., obtained in rat, were rather encouraging (Lescure et aI
PMM unloaded (1994)
actinomycin D injected into rats, Biochem.Soc.Trans
Black (1976)
Characterization of a functional NF-KB site in the human interleukin 1~ promoter: evidence for a positive autoregulatory loop, MoI.Cell BioI
J. Hiscott (1993)
10.1016/0378-5173(92)90348-6
Novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradation
M. Morishita (1992)
10.1016/0021-9150(91)90222-O
Inhibition of IL-1β expression in THP-1 cells by probucol and tocopherol
A. Akeson (1991)
10.1172/JCI112491
Infection of monocyte/macrophages by human T lymphotropic virus type III.
D. Ho (1986)
10.1016/0005-2736(89)90078-3
Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues.
T. Allen (1989)
10.1111/J.1432-1033.1972.TB19710.X
Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases.
G. Gregoriadis (1972)
10.1016/0378-5173(92)90162-U
Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat
P. U. Jani (1992)
HIV reduced sensitivity to zidovudine
Larder (1989)
Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation.
E. Herman (1983)
Reverse transcriptase stepwise mechanism: Phosphorothioate oligodeoxynuleotides as primer
Majumdar (1989)
10.1016/s0021-9258(18)32864-3
Binding of fibronectin to phospholipid vesicles.
J. Rossi (1983)
10.1016/0014-5793(92)80655-Z
The polyoxyethylene/polyoxypropylene block co‐polymer Poloxamer‐407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow
C. Porter (1992)
10.1016/0014-5793(80)80994-X
The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the circulation
G. Gregoriadis (1980)
10.1002/HEP.1840160137
Liver endocytosis and Kupffer cells
C. A. Toth (1992)
10.1126/SCIENCE.1699273
Molecular targets for AIDS therapy.
H. Mitsuya (1990)
10.1111/J.1432-1033.1974.TB03681.X
Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats. Possible therapeutic applications.
G. Gregoriadis (1974)
Human recombinant interleukin-l stimulates collagenase and prostaglandin Ez production by human synovial cells, J.Clin.Invest
Dayer (1986)
10.1016/0006-291X(79)92148-X
Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells.
G. Gregoriadis (1979)
10.1111/J.1470-8744.1988.TB00011.X
Targeting of mycotoxins to reticuloendothelial system of mice with carrier erythrocytes
J. Deloach (1988)
Biodegradable particies containing
P. Couvreur (1982)
Self-associating IgG rheumatoid factors, in: "New Horizons in Rheumatoid Arthritis
M. Mannik (1983)
10.1111/j.2042-7158.1989.tb06377.x
The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats
P. Jani (1989)
10.1016/0142-9612(91)90119-U
Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells in vitro.
G. Harper (1991)
Antisense oligonucleotides: inhibition of liver cell proliferation and in vivo disposition.
M. Inagaki (1992)
Liposomes for sustained release in vivo, Biochim.Biophys
G. Blume (1990)
10.1016/0378-5173(88)90255-4
Poloxamer sorption on liposomes: comparison with polystyrene latex and influence on solute efflux
M. Jamshaid (1988)
10.1016/0021-9797(92)90079-2
Optimization of polyalkylcyanoacrylate nanoparticle preparation: Influence of sulfur dioxide and pH on nanoparticle characteristics
F. Lescure (1992)
Antisense RNA and DNA.
J. A. Murray (1992)
10.1089/ARD.1993.3.67
Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells.
P. Yaswen (1993)
Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene.
S. Huang (1993)
10.1111/j.2042-7158.1991.tb05437.x
The Effect of Site of Administration in the Gastrointestinal Tract on the Absorption of Insulin from Nanocapsules in Diabetic Rats
C. Michel (1991)
Regulation of viral expression of HIV in vitro by antisense phosphorothioate oligodeoxynucleotide against rev, Proc.NatI.Acad.Sci.USA
M. Matsukura (1989)
The gradient of mucosal surface area in the small intestine of the rat.
R. Fisher (1950)
10.1089/SCT.1989.5.1
Doxorubicin-loaded nanoparticles: increased efficiency in murine hepatic metastases.
N. Chiannilkulchai (1989)
10.1016/0165-2478(92)90227-F
Suppression of interleukin 4 production from type 2 helper T cell clone by antisense oligodeoxynucleotide.
M. Hikida (1992)
Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice.
I. Ahmad (1993)
10.1038/bjc.1988.293
A cytotoxic agent can be generated selectively at cancer sites.
K. D. Bagshawe (1988)
10.1007/978-94-011-2980-0
Immunology of HIV Infection
A. Bird (1992)
Recent advances in drug
developing brain (1991)
Molecular and cellular basis of immune
J. P. Kroehenbuhl (1992)
Targeted cellular immunotherapy with bifunctional antibodies.
H. Nelson (1991)
10.1073/PNAS.85.18.6949
Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.
A. Gabizon (1988)
10.1016/0378-5173(92)90349-7
Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats
I. Morishita (1992)
Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma.
J. Vaage (1979)
1992b, Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single dose
P. U. Jani (1992)
10.1016/0032-3861(92)90034-T
The surface characterization of model charged and sterically stabilized polymer colloids by SSIMS and X.p.s.
A. Brindley (1992)
New approach for oral administration of insulin with polyalky1cyanoacrylate nanacapsules as drug carrier, Diabetes
Michel (1988)
[Feline immunodeficiency virus (FIV)].
H. Egberink (1989)
Oral delivery of peptides and proteins, in: "Perspectives in Medicinal Chemistry
S. S. Davis (1993)
Intestinal translocation of particulates-implications of drug and antigen delivery, Adv.Drug Deliv.Rev
D. T. O'Hagan (1990)
10.3181/00379727-179-42133
Retention of Ingested Latex Particles in Peyer's Patches of Germfree and Conventional Mice 1
M. Lefevre (1985)
Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice.
S. Huang (1992)
10.1016/s0079-6603(08)60574-7
Oligodeoxynucleotides as antisense inhibitors of gene expression.
M. Ghosh (1992)
Antisense phosphoro
A. Storey (1991)
Lipid on
E. C. Gotschlich (1981)
10.1016/0378-5173(92)90210-S
Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length
C. Lherm (1992)
10.1016/0142-9612(92)90177-P
Human serum albumin as a probe for surface conditioning (opsonization) of block copolymer-coated microspheres.
M. E. Norman (1992)
10.1002/IJC.2910510221
Pharmacokinetics and antitumor activity of epirubicin encapsulated in long‐circulating liposomes incorporating a polyethylene glycol‐derivatized phospholipid
E. Mayhew (1992)
10.1111/j.2042-7158.1979.tb13510.x
Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties
P. Couvreur (1979)
Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue.
N. Wu (1993)
10.1007/978-94-011-1524-7_22
In vitro selection
G. Wenzel (1993)
Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
C. Bennett (1992)
10.1128/IAI.43.2.693-699.1984
Morphological study of antigen-sampling structures in the rat large intestine.
P. Bland (1984)
10.1073/PNAS.86.10.3474
Characterization of oligonucleotide transport into living cells.
S. Loke (1989)
10.1016/S0092-8240(05)80385-4
A nonlinear three-compartment model for the administration of 2',3'-dideoxycytidine by using red blood cells as bioreactors.
F. Solimano (1990)
10.1089/ARD.1993.3.3
Predictions of effect for intracellular antisense oligodeoxyribonucleotides from a kinetic model.
M. Ramanathan (1993)
HIV-l tropism for mononuclear phagocytes
I.S.Y. Chen (1990)
Changing needs in drug delivery in the era of peptide and protein drugs
V. Lee (1991)
Oral and parenteral
P. Couvreur (1980)
10.1042/BST0030613
Homing of liposomes to target cells.
G. Gregoriadis (1975)
Liposome fornmlations with prolonged circulation time in blood and enhanced uptake by tumors, Proc.NatI.Acad.Sci.USA
A. Gabizon (1988)
Synthesis and evaluation of a new biodegradable monomer, Proceed.Intern.Symp.Control.Rel.Bioact
F. Lescure (1991)
SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT : TISSUE
10.1016/0140-6736(93)90006-3
Balance of synovial fluid IL-1β and IL-1 receptor antagonist and recovery from Lyme arthritis
L. Miller (1993)
10.1016/S0006-291X(75)80433-5
The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs.
R. Juliano (1975)
10.1016/0304-4157(92)90038-C
Sterically stabilized liposomes.
M. Woodle (1992)
Antisense DNA treatment of HL-60 promyelocytic leukemia
E. Wickstrom (1991)
The binding
H. C. Loughrey (1990)
10.1021/JA00031A062
Peptide nucleic acids (PNA) : oligonucleotide analogues with an achiral peptide backbone
M. Egholm (1992)
Interleukin-l acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell
M. P. Bevilacqua (1985)
10.1073/PNAS.87.15.5744
Lipid composition is important for highly efficient target binding and retention of immunoliposomes.
K. Maruyama (1990)
10.1093/JAC/20.SUPPL_B.47
Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells.
M. Carlier (1987)
10.1126/SCIENCE.7681216
Phosphorodithioate DNA as a potential therapeutic drug.
W. S. Marshall (1993)
10.1093/NAR/19.20.5551
Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (liposomes).
S. Akhtar (1991)
10.1016/0264-410X(89)90231-4
Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunization.
D. O'hagan (1989)
10.1016/0163-7258(83)90010-4
Delivery of liposome-encapsulated drugs to macrophages.
C. Alving (1983)
10.1016/0142-9612(84)90002-4
Degradation of poly (isobutyl cyanoacrylate) nanoparticles.
V. Lenaerts (1984)
10.1007/978-3-642-74006-0_38
Delivery of c-myc antisense phosphorothioate oligodeoxynucleotides to hematopoietic cells in culture by liposome fusion: specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis.
S. Loke (1988)
10.1016/0008-8749(92)90205-4
N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production.
P. Peristeris (1992)
Red blood cells as carriers for drugs
J. Deloach (1985)
Biological approaches to the controlled delivery of drugs: a critical review.
M. Poznansky (1984)
Clinical efficacy of tirilazad mesylate for treatment of endotoxemia in neonatal calves.
M. Rose (1992)
10.1016/0378-5173(91)90246-K
Oral vaccines: Design and delivery
C. A. Gilligan (1991)
10.1042/BST0020869
Intracellular Fate and Effect of Liposome-Entrapped Actinomycin D Injected into Rats
D. Christopher (1974)
10.1016/S0040-4020(01)86764-8
Synthesis of new acylpseudopeptides analogous to n-acetylmuramyl dipeptide (MDP)
P. Breton (1990)
Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes).
J. W. Cowens (1993)
10.1038/244170A0
Enzyme-containing Liposomes alleviate a Model for Storage Disease
G. Gregoriadis (1973)
10.1093/JNCI/85.2.90
Opportunities "opening up" for gene therapy.
C. Vanchieri (1993)
10.1016/s0021-9258(18)54327-1
Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis.
F. Turrini (1991)
10.1099/0022-1317-71-12-3021
Antisense oligodeoxyribonucleotides inhibit the expression of the gene for hepatitis B virus surface antigen.
G. Goodarzi (1990)
10.1080/15287398009529888
Intestinal barrier to large particulates in mice.
M. Lefevre (1980)
10.1016/0006-291X(91)91869-E
Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating.
S. Moghimi (1991)
In vitro heterogeneous degradation of poly(n-alkyl alpha-cyanoacrylates).
W. R. Vezin (1980)
10.1073/PNAS.88.23.10591
Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein.
K. Scanlon (1991)
Inhibitors of Oncogene expression in tumor cells and tools for gene function analysis, in: Gene Regulation: Biology of Antisense RNA and DNA317-328
K. H. Schlingensiepen (1992)
The uptake
IntJ.Pharm (1989)
Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes.
A. Gabizon (1992)
10.1111/j.1749-6632.1975.tb51092.x
HEMATOGENOUS DISSEMINATION OF INGESTED POLYVINYL CHLORIDE PARTICLES
G. Volkheimer (1975)
10.1021/BI00150A025
Involvement of reactive oxygen intermediates in the induction of c-jun gene transcription by ionizing radiation.
R. Datta (1992)
target binding with long circulation times, Biochim.Biophys.Acta
F. Emmen (1987)
Some long-acting antirheumatic drugs and antioxidants induce differentiation of macrophage lineage cells and augment expression of the IL-1 receptor antagonist IL-1ra, Ann.N.Y.Acad.Sci
R. V. Waters (1993)
For histological analysis, frozen sections of the various organs were prepared using a cryostat and the particles viewed with a fluorescent microscope
Jani (1992)
10.1111/j.2042-7158.1990.tb07033.x
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
P. Jani (1990)
10.1096/fasebj.6.9.1612296
Targeted accumulation of polyethylene glycol‐coated immunoliposomes in infarcted rabbit myocardium
V. Torchilin (1992)
10.1002/JPS.2600800117
Poly(diethyl methylidenemalonate) nanoparticles as a potential drug carrier: preparation, distribution and elimination after intravenous and peroral administration to mice.
J. De Keyser (1991)
10.1002/ART.1780330302
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.
W. P. Arend (1990)
10.1093/INFDIS/168.1.164
Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue.
I. A. Bakker-Woudenberg (1993)
10.1016/0166-3542(90)90034-5
Complementary oligonucleotide sequence inhibits both Vmw65 gene expression and replication of herpes simplex virus.
K. G. Draper (1990)
10.1016/0378-5173(91)90134-A
The effect of poloxamer-407 on liposome stability and targeting to bone marrow: comparison with polystyrene microspheres
S. Moghimi (1991)
10.1016/0168-3659(93)90175-5
Microspheres for targeting drugs to specific body sites
S. Davis (1993)
10.1093/JNCI/81.19.1484
Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times.
A. Gabizon (1989)
10.1002/IJC.2910510618
Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes
J. Vaage (1992)
10.1042/BJ1860591
Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro.
C. Kirby (1980)
10.1163/156856292X00105
Is the Vroman effect of importance in the interaction of blood with artificial materials?
E. Leonard (1991)
10.1089/ARD.1992.2.111
Translation inhibition by phosphorothioate oligodeoxynucleotides in cell-free systems.
M. Ghosh (1992)
Reactive oxygen intermediates as apparently widely used messengers in the activation of NEKB transcription factor and HIV-1, EmboJ
R. Schrek (1991)
Hoematogenolls dissemiation of ingested polyvinyJchloride particles, Ann.N
G. olkheimer (1983)
Colloidal delivery systems: opportunities and challenges, in: "Site-specific drug delivery
S. S. Davis (1986)
10.1128/MCB.11.5.2804
Rapid and preferential activation of the c-jun gene during the mammalian UV response.
Y. Devary (1991)
10.1073/PNAS.84.3.648
Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site.
M. Lemaitre (1987)
10.1016/0005-2736(93)90115-G
Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection.
T. Allen (1993)
10.1136/gut.34.10.1357
Distribution of macrophages and granulocytes expressing L1 protein (calprotectin) in human Peyer's patches compared with normal ileal lamina propria and mesenteric lymph nodes.
K. Bjerke (1993)
10.1016/0166-3542(91)90023-K
Vmw65 phosphorothioate oligonucleotides inhibit HSV KOS replication and Vmw65 protein synthesis.
M. Kmetz (1991)
10.1016/0014-5793(73)80394-1
Drug entrapment in liposomes
G. Gregoriadis (1973)
In vivo cytotoxicity and antineoplastic activity of a transferrin-daunorubicin conjugate.
P. Lemieux (1992)
10.1016/0014-5793(84)80836-4
The organ uptake of intravenously administered colloidal particles can be altered using a non‐ionic surfactant (Poloxamer 338)
L. Illum (1984)
10.1201/9780203748831-8
Receptor-dependent targeting of lipoproteins to specific cell types of the liver.
T. V. van Berkel (1991)
10.1096/fasebj.5.10.2065888
Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis
P. Jolicoeur (1991)
10.1016/0024-3205(87)90138-X
The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908.
L. Illum (1987)
10.1002/j.1460-2075.1993.tb05767.x
In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides.
W. Offensperger (1993)
Klebsiella pneumoniae infected lung tissue, 1.Tnfec.Dis
G. Blume (1990)
10.1016/0378-5173(94)90064-7
The quantitation of the absorption of microparticles into the intestinal lymph of Wistar rats
P. G. Jenkins (1994)
Release of human hematopoeitic progenitors from quiescence by antisense transforming growth factor 1 or Rb oligonucleotides, J.Exp.Med
J. P. Levesque (1991)
Nanoparticle uptake
P. Jani (1990)
10.1016/0378-5173(90)90148-W
A procedure for the efficient entrapment of drugs in dehydration-rehydration liposomes (DRVs)
G. Gregoriadis (1990)
10.1016/0169-409X(89)90027-6
Antibody-directed liposomes as drug-delivery vehicles
S. E. Wright (1989)
In vitro evaluation of phosphorothioate oligonucleotides targeted to the E2 mRNA of papilloma virus: potential treatment for genital warts, Antimicrobial Agents
L. M. Cowsert (1993)
10.1016/0005-2736(89)90306-4
Differential properties of organ-specific serum opsonins for liver and spleen macrophages.
S. Moghimi (1989)
Antisense c-myb
M. Simons (1992)
10.1007/978-1-4615-3030-5
The Use of Resealed Erythrocytes as Carriers and Bioreactors
M. Magnani (1992)
StericaUy stabilized liposomes: improvements in pharmacokinetics, tissue disposition and antitumour therapeutic efficacy, Proc.NatI.Acad.Sci.USA
A Gabizon (1991)
Preparation and Use of Liposomes in Immunological Studies
C. Alving (1993)
10.1016/0005-2736(92)90084-Y
In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release.
A. Horowitz (1992)
Subcutaneous ll..-1 receptor antagonist in patients with rheumatoid arthritis
M. E. Lebsack (1991)
The adsorption of plasma and serum proteins to block copolymer coated microspheres, Biomaterials
M. E. Norman (1993)
10.1073/PNAS.86.17.6553
Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture.
R. Letsinger (1989)
Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor.
G. Chaudhri (1989)
10.1073/PNAS.88.17.7595
Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
S. Agrawal (1991)
10.1084/JEM.171.1.35
Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages
A. Shakhov (1990)
Antisense oligonucleotides and ribonucleases H, Biochemie
J. J. Toulme (1993)
Red blood cell targeting
D. V. Sakharov (1986)
Toxicité des nanosphères à base de polycyanoacrylates d'alkyle
P. Couvreur (1989)
A new application for Iiposomes in cancer
G. Storm (1993)
Effect of phosphorothioates homo-oligonucleotides on herpes simplex virus type 2 Induced DNA polyermerase, J.Biol.Chem
W. Gao (1989)
Guest editorial: GEM91, An antisense oligonucleotide
S. Agrawal (1993)
Compositions pharmaceutiqlles contenant de I'insuline pour utilisation dans Ie traitement du diabete et procede de preparation de telles compositions pharmaceutiques
C. Michel (1990)
Antisense-mediated inhibition of BCL2 proto-oncogene expression and leukemic cell growth; comparisons of phosophorothioate oligonucleotides
Reed (1990)
10.1016/0076-6879(87)49060-5
High-efficiency entrapment of enzymes in resealed red cell ghosts by dialysis.
G. Dale (1987)
10.1042/BST0051380
Fate of a liposome-associated agent injected into normal and tumour-bearing rodents: attempts to improve localization in tumour tissues [proceedings].
E. D. Neerunjun (1977)
Sterically stabilized liposomes, Biochim
M. C. Woodle (1992)
10.1126/SCIENCE.8430321
Inhibition of neural crest cell attachment by integrin antisense oligonucleotides
T. Lallier (1993)
10.1089/ARD.1991.1.141
Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3' exonuclease in plasma.
P. Eder (1991)
10.1016/S0006-291X(76)80149-0
The in vivo transformation of phospholipid vesicles to a particle resembling HDL in the rat.
L. Krupp (1976)
10.1016/0014-5793(93)81177-2
Polysialic acids: potential in drug delivery
G. Gregoriadis (1993)
10.3109/10611869308998758
Liposomes, a tale of drug targeting.
G. Gregoriadis (1993)
Delivery of antisense oligonucleotides by poly(L-lysine) conjugation and liposome encapsulation.
J. Clarenc (1993)
Guest editorial: systematic human antisense therapy
E. Bayever (1992)
Cytokines and bone, BrJ.Rheumatol
B. R. MadDonald (1992)
Avidin attachment
102753 Muzykantov (1993)
Degradation of poly(isobutylcyanoacrylate) nanoparticles, Biomaterials
P. Speiser (1984)
Controlled vaccine release in the gut associated lymphoid tissue. I. Orally administered biodegradable microspheres target the Peyer's patches, J.ControI.Rel
Eldridge (1990)
10.1128/IAI.49.3.587-592.1985
Effect of aluminum ions on chemical and immunological properties of meningococcal group B polysaccharide.
C. Moreno (1985)
10.1016/S0008-6215(00)90104-6
Analysis of the chain length of oligomers and polymers of sialic acid isolated from Neisseria meningitidis group B and C and Escherichia coli K1 and K92.
M. R. Lifely (1986)
10.1016/0014-5793(91)80699-4
Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo
A. Mori (1991)
10.1073/PNAS.89.24.11823
In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.
M. Ratajczak (1992)
10.1016/0264-410X(89)90156-4
Microparticles as potentially orally active immunological adjuvants.
D. O'hagan (1989)
B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.
Y. Takai (1988)
starch microparticles as carriers for proteins and drugs, 1.Pharm.Sci
P. Artursson (1984)
10.1016/0378-5173(87)90184-0
Immobilized L-asparaginase-L-glutaminase from Acinetobacter glutaminasificans in microspheres: some properties in vivo and in an extracorporeal system
P. Edman (1987)
Prostagladin induced in vascular endothelial cells
V. Rossi (1985)
A monoclonal antibody-~-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer, Br.J.Cancer
H.I (1992)
phagocytic transport of intestinal particles in dogs and rats
J.L (1984)



Semantic Scholar Logo Some data provided by SemanticScholar